Last reviewed · How we verify

NCT05969093

Refining the Interpretation of the Tinel's Sign for Carpal Tunnel Syndrome

Status unknown Last updated 1 August 2023
What this trial tests

trial testing Tinel's Sign performed at different wrist positions in Carpal Tunnel Syndrome in 30 participants. Status unknown.

Timeline
29 July 2023
Primary endpoint
23 December 2023
1 January 2024

Quick facts

Lead sponsorAhram Canadian University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment30
Start date29 July 2023
Primary completion23 December 2023
Estimated completion1 January 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ahram Canadian University

Who can join

Adults 18 to 60, any sex, with Carpal Tunnel Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an observational study to investigate the electromyographic (EMG) activity and nerve conduction velocity (NCV) of healthy individuals during the Tinel's Sign performed at different wrist positions. The study aims to identify the wrist position that best isolates median nerve activity during the Tinel's Sign.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Carpal Tunnel Syndrome

Currently open trials in the same condition.

Other Ahram Canadian University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05969093.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing